Mesa Laboratories Inc

1. 1

   Election of Directors

   ManagementBoard: FOR

   Elect seven director nominees named in the Proxy Statement to serve one-year terms until the 2027 annual meeting.

2. 2

   Ratification of the Selection of Baker Tilly US, LLP as Independent Registered Public Accounting Firm

   ManagementBoard: FOR

   Ratify the Audit Committee’s appointment of Baker Tilly US, LLP as Mesa’s independent registered public accounting firm for the fiscal year ending March 31, 2027.

3. 3

   Advisory Vote on Named Executive Officer Compensation (Say-on-Pay

   ManagementBoard: FOR

   Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement, including the CD&A, compensation tables, and narrative disclosures.

   More detail

   This management proposal asks shareholders to cast a non-binding advisory vote to approve the Company’s disclosed executive compensation (a say-on-pay vote). Management is seeking shareholder endorsement to validate its compensation design and governance approach, which emphasizes pay-for-performance with a majority of executive pay at risk (annual cash incentives and long-term PSUs/RSUs). The Compensation Committee has designed PSUs based solely on relative total shareholder return measured against the S&P Composite 1500 Healthcare Index over a three-year period and increased post-vesting holding periods to strengthen long-term alignment. The Board cites robust shareholder engagement and high prior say-on-pay support (94.2% in 2025) as context and argues that the current program balances short-term operational metrics (revenues and adjusted operating income) with long-term TSR-based incentives. The advisory nature of the vote means it is non-binding, but the Board commits to reviewing results and considering shareholder feedback when designing future programs. Company-specific context includes a recent CEO transition and active outreach to large shareholders, which the Board says informed changes to PSU design and holding requirements. Voting FOR would signal shareholder support for the Board’s current compensation philosophy and metrics; a significant vote against could prompt the Compensation Committee to reassess program elements and further engage with investors.

Upcoming shareholder meetings at Mesa Laboratories Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Mesa Laboratories Inc 2026 annual meeting?

Mesa Laboratories Inc (MLAB) holds its 2026 annual shareholder meeting on Tuesday, September 8, 2026.

What is the record date for the Mesa Laboratories Inc 2026 meeting?

The record date for the Mesa Laboratories Inc 2026 meeting is Friday, July 10, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Mesa Laboratories Inc's 2026 meeting?

The board is presenting 7 director nominees at the Mesa Laboratories Inc 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Mesa Laboratories Inc 2026 meeting?

Shareholders will vote on 3 proposals at the Mesa Laboratories Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.